Abstract:Dengyun Pan, Xin Di, Bingdi Yan, Xiaomin Su Department of Respiratory Medicine, The Second Hospital of Jilin University, Changchun, People's Republic of China Correspondence: Bingdi Yan; Xiaomin Su, Department of Respiratory Medicine, The Second Hospital of Jilin University, 218 Ziqiang Street, Changchun, 130041, People's Republic of China, Email ; Pulmonary fibrosis is a group of chronic, progressive, and irreversible interstitial lung diseases, which are common to most end-stage lung diseases and are one of the most difficult diseases of the respiratory system. In recent years, due to the frequent occurrence of air pollution and smog, the incidence of pulmonary fibrosis in China has increased year by year, the morbidity and mortality rates of pulmonary fibrosis have gradually increased and the age of the disease tends to be younger. However, the pathogenesis of pulmonary fibrosis is not yet fully understood and is needed to further explore new drug targets. Studies have shown that non-coding RNAs play an important role in regulating the process of pulmonary fibrosis, non-coding RNAs and their specifically expressed can promote or inhibit the process. Here, we review the role of some in the regulation of pulmonary fibrosis signaling pathways and provide new ideas for the clinical diagnosis and treatment of pulmonary fibrosis. Keywords: pulmonary fibrosis, MicroRNA, LncRNA, CircRNA, signaling pathways Pulmonary fibrosis is a terminal change of interstitial lung disease (ILD). It is an abnormal repair process in cases of persistent microdamage to the alveolar epithelium caused by a variety of factors, during which, as the inflammatory response progresses, fibroblasts proliferate and differentiate abnormally, and the extracellular matrix accumulates excessively leading to scar formation in the lung. 1,2 As the disease worsened, altered normal lung tissue structure, reduced compliance, and restricted gas exchange, leading to progressive loss of lung function and eventually respiratory failure and even death. In recent years, the exploration of the pathogenesis and treatment of pulmonary fibrosis at the genomic level has become a major research hotspot, 3 especially in the area of non-coding RNAs (ncRNAs). 4 Non-coding RNAs are RNAs that do not encode proteins. The common feature of these RNAs is that they can be transcribed from the genome, but are not translated into proteins and can perform their respective biological functions at the RNA level. 5 This review focuses on outlining the targets of some miRNAs, lncRNAs, and circRNAs among ncRNAs in the signaling pathway of pulmonary fibrosis, and we look forward to providing a theoretical basis for the clinical management of pulmonary fibrosis. MiRNAs are a class of small ncRNAs about 20–24 nucleotides long encoded by endogenous genes. It is involved in a variety of important physiological and pathological processes in the body, mainly by degrading target mRNAs or inhibiting their translation level through base pairing with the untranslated region at the 3' end of the target mRNA. 6,7 MiRNAs are up- or down-regulated in fibrotic lung tissues. Therefore, they are divided into pro-fibrotic miRNAs and anti-fibrotic miRNAs (Table 1). Hence, targeting these differentially expressed miRNAs could provide a potential therapeutic strategy for pulmonary fibrosis. Table 1 Expression Levels and Targets of miRNAs in Pulmonary Fibrosis Transforming growth factor-β (TGF-β) belongs to the TGF-β superfamily, a group of regulatory cytokines. It plays an essential role in cell growth, differentiation, extracellular matrix synthesis, apoptosis, immunosuppression, and damage repair. Of the three isoforms of TGF-β, TGF-β1 is considered a key factor in the development of pulmonary fibrosis. 8,9 In pulmonary fibrosis, TGF-β1 acts in five ways: 9–14 (1) by promoting extracellular matrix deposition; (2) by promoting the proliferation and aggregation of fibroblasts and their conversion into myofibroblasts; (3) by promoting the epithelial-mesenchymal transition (EMT) process; (4) by regulating immune responses and performing microenvironmental modifications; (5) by acting as a pro-angiogenic factor, to promoting angiogenesis in fibrotic areas; and (6) by inducing multiple cells to secrete senescence-associated secretory phenotypes that drive pulmonary fibrosis through senescence. Smad proteins are a class of intracellular signaling molecules downstream of the TGF-β superfamily, and they play an important role in transmitting TGF-β signals from the extracellular to the nucleus. In the TGF-β/Smad signaling pathway, TGF-β ligands bind to heterodimeric complexes of type II and type I receptors, phosphorylating type II receptors and activating type I receptors. Activated type I receptors phosphorylat -Abstract Truncated-

Hypoxia and Transforming Growth Factor 1 Regulation of Long Non-Coding RNA Transcriptomes in Human Pulmonary Fibroblasts

LncRNA Hoxaas3 Promotes Lung Fibroblast Activation and Fibrosis by Targeting Mir-450B-5p to Regulate Runx1.

Advances in the Study of Non-Coding RNA in the Signaling Pathway of Pulmonary Fibrosis

Changing Expression Profiles of Messenger RNA, MicroRNA, Long Non-coding RNA, and Circular RNA Reveal the Key Regulators and Interaction Networks of Competing Endogenous RNA in Pulmonary Fibrosis

The lncRNA H19 Mediates Pulmonary Fibrosis by Regulating the miR-196a/COL1A1 Axis

Hypoxia Induces Pulmonary Fibroblast Proliferation Through NFAT Signaling.

Systematic analyses identify the anti-fibrotic role of lncRNA TP53TG1 in IPF

Persistent hypoxia promotes myofibroblast differentiation via GPR-81 and differential regulation of LDH isoenzymes in normal and idiopathic pulmonary fibrosis fibroblasts

Regulation of idiopathic pulmonary fibrosis: a cross-talk between TGF- β signaling and MicroRNAs

Effect of Hypoxia on Fibroblast Proliferation in Idiopathic Pulmonary Fibrosis

Regulation of extracellular matrix gene expression and biosynthetic pathways in pulmonary fibroblasts by HSF1

Long non-coding RNA H19 deficiency ameliorates bleomycin-induced pulmonary inflammation and fibrosis

miR-627/HMGB1/NF-κB regulatory loop modulates TGF-β1-induced pulmonary fibrosis.

Interaction of Long Noncoding RNAs and Micrornas in the Pathogenesis of Idiopathic Pulmonary Fibrosis.

The gene expression of CALD1, CDH2, and POSTN in fibroblast are related to idiopathic pulmonary fibrosis

LncRNA PFAR Contributes to Fibrogenesis in Lung Fibroblasts Through Competitively Binding to Mir-15A.

LncRNA CTD-2528L19.6 prevents the progression of IPF by alleviating fibroblast activation

Hypoxia-inducible factor-1α mediates TGF-β-induced PAI-1 production in alveolar macrophages in pulmonary fibrosis

lncITPF Promotes Pulmonary Fibrosis by Targeting hnRNP-L Depending on Its Host Gene ITGBL1

TGFβ1-RCN3-TGFBR1 loop facilitates pulmonary fibrosis by orchestrating fibroblast activation

Bulk RNA-Sequencing of small airway cell cultures from IPF and post-COVID lung fibrosis patients illustrates disease signatures and differential responses to TGF-β1 treatment